NOT KNOWN FACTS ABOUT SEMAGLUTUDE WEEKS 13-16 BUNDLE

Thyroid C-mobile Tumors: In rodent reports, semaglutide has been shown to lead to thyroid C-mobile tumors. It is unknown no matter if this possibility applies to human beings, but semaglutide is contraindicated in patients with a private or relatives record of medullary thyroid carcinoma (MTC) or sufferers with Various Endocrine Neoplasia syndrome